News: Molecular Biosciences

McLellan, who will be inducted in Washington, D.C. on May 8, is among the youngest new inductees in hall of fame history.

Ilya Finkelstein’s research focuses on improving gene editing, understanding DNA repair and finding disease treatments.

Researchers from UT Austin have discovered insights about an enzyme that can protect cells from oxidative stress.

Biotech advances from UT’s new Deep Proteins group are changing the game with help from artificial intelligence.

EvoRank offers a new and tangible example of how AI may help bring disruptive change to biomedical research and biotechnology more broadly.

Familiar faces and newcomers alike are among the 13 newest tenured and tenure-track faculty members joining the college.

Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection.

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as similar coronaviruses.

Professor of molecular biosciences David Hoffmann helped develop a new way to fingerprint a type of forever chemical.

Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.